Tumor, malnutrition
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 90 years, no gender limit; 2. Patients diagnosed with digestive system tumors; 3. Patients with 28g/L=3 points; 5. Able to understand the purpose of the trial, voluntarily participate in and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Those who are allergic to the ingredients contained in research supplies; 2. People with severe systemic diseases (such as cardiovascular, respiratory, digestive, neurological, endocrine, genitourinary diseases, etc.) and unstable conditions, such as brain and bone metastases, large amounts of pleural fluid, etc.; 3. Those who suffer from mental illness, including severe hysteria, and are involuntary; 4. Liver function damage: ALT or AST is greater than 3 times the upper limit of normal; 5. Abnormal renal function: serum creatinine (Cr) is greater than 1.5 times the upper limit of normal; 6. History of drug abuse or alcohol abuse; 7. Participate in other drug clinical trials within 30 days before this trial; 8. The investigator judged that the patient had poor compliance and could not complete the study as required; 9. Albumin was injected during the test period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| albumin;Total protein;Prealbumin;Retinol binding protein; | — |
Secondary
| Measure | Time frame |
|---|---|
| Lean body mass;Transferrin;Immunoglobulin A;Immunoglobulin M;Immunoglobulin G;Interleukin-6;High-sensitivity C-reactive protein;Tumor necrosis factor; | — |
Countries
China
Contacts
Department of Clinical Nutrition, Shanghai Changhai Hospital